BioTuesdays

Category - Markets

Markets

HCW starts Personalis at buy; PT $30

H.C Wainwright launched coverage of Personalis (NASDAQ:PSNL) with a “buy” rating and $30 price target. The stock closed at $21.88 on Aug. 26. Personalis is a developer of next generation sequencing technologies and...

August 27, 2020
Onconova Logo
Markets

HCW cuts Onconova Therapeutics to neutral; removes PT

H.C. Wainwright downgraded Onconova Therapeutics (NASDAQ:ONTX) to “neutral” from “buy” without a price target after the company’s Phase 3 INSPIRE trial with rigosertib in high-risk myelodysplastic syndromesfailed on...

August 24, 2020
Markets

Brookline starts 9 Meters Biopharma at buy; PT $5

Brookline Capital Markets initiated coverage of 9 Meters Biopharma (NASDAQ:NMTR) with a “buy” rating and $5 price target. At midday on Aug. 20, the stock was quoted at 68 cents. 9 Meters is focused on two...

August 20, 2020
iTeos Logo
Markets

SVB Leerink starts iTeos Therapeutics at OP; PT $36

SVB Leerink launched coverage of iTeos Therapeutics (NASDAQ:ITOS) with an “outperform” rating and $36 price target. The stock closed at $32.92 on Aug. 18. “Though the stock has rallied since the IPO, we see potential...

August 18, 2020
Nurix Logo
Markets

Stifel starts Nurix Therapeutics at buy; PT $34

Stifel initiated coverage of Nurix Therapeutics (NASDAQ:NRIX) with a “buy” rating and $34 price target. The stock closed at $27 on Aug. 17. Nurix is a soon-to-be-clinical-stage company focused on the discovery...

August 18, 2020
Markets

Maxim ups TFF Pharma PT to $18 from $12

Maxim Group raised its price target for TFF Pharmaceuticals (NASDAQ:TFFP) to $18 from $12, citing a new partnership with Union Therapeutics that further validates TFF’s platform potential. The stock closed at $11.55 on...

August 17, 2020
atyr logo
Markets

HCW ups aTyr Pharma to buy; PT $13

H.C. Wainwright upgraded aTyr Pharma (NASDAQ:LIFE) to “buy” from “neutral” with a $13 price target, citing a “positive shift” at the company ahead of anticipated news flow. The stock closed at $3.81 on Aug. 14. Analyst...

August 17, 2020
Itamar Medical
Markets

AGP ups Itamar Medical PT to $28 from $22.75

Alliance Global Partners raised its price target for Itamar Medical (NASDAQ:ITMR) to $28 from $22.75 after the company’s second quarter results beat expectations. However, the stock closed at $22.02, down $3.84, on Aug...

August 12, 2020
Senseonics
Markets

BTIG ups Sensenonics to buy; PT to $1

BTIG upgraded Sensenonics Holdings (NYSE American:SENS) to “buy” from “neutral” with a price target of $1, citing a commercial collaboration with Ascensia Diabetes Care, a financing agreement with Ascensia’s parent, PHC...

August 11, 2020